Abstract
Simple SummarySquamous cell carcinomas of the upper aerodigestive tract are highly incident, lethal, and share the same epithelial lining of origin, risk factors and genetic alterations. However, their biological and clinical behaviors differ, having an impact on patient survival. This study aimed at identifying the main DNA methylation differences between these tumors, giving an overview of the main genomic regions affected, whether DNA methylation gains or losses are more common, the impact on gene expression and the signaling pathways affected. This knowledge will help identifying potential site-specific biomarkers as well as shedding light on whether epigenetic mechanisms explain, at least in part, the diverse behavior of upper aerodigestive tract tumors.Upper aerodigestive tract (UADT) tumors present different biological behavior and prognosis, suggesting specific molecular mechanisms underlying their development. However, they are rarely considered as single entities (particularly head and neck subsites) and share the most common genetic alterations. Therefore, there is a need for a better understanding of the global DNA methylation differences among UADT tumors. We performed a genome-wide DNA methylation analysis of esophageal (ESCC), laryngeal (LSCC), oral (OSCC) and oropharyngeal (OPSCC) squamous cell carcinomas, and their non-tumor counterparts. The unsupervised analysis showed that non-tumor tissues present markedly distinct DNA methylation profiles, while tumors are highly heterogeneous. Hypomethylation was more frequent in LSCC and OPSCC, while ESCC and OSCC presented mostly hypermethylation, with the latter showing a CpG island overrepresentation. Differentially methylated regions affected genes in 127 signaling pathways, with only 3.1% of these being common among different tumor subsites, but with different genes affected. The WNT signaling pathway, known to be dysregulated in different epithelial tumors, is a frequent hit for DNA methylation and gene expression alterations in ESCC and OPSCC, but mostly for genetic alterations in LSCC and OSCC. UADT tumor subsites present differences in genome-wide methylation regarding their profile, intensity, genomic regions and signaling pathways affected.
Highlights
Upper aerodigestive tract (UADT) tumors are highly incident worldwide and their prognosis vary according to tumor subsite and affected population [1,2]
24 esophageal squamous cell carcinoma (ESCC) patients, 21 laryngeal squamous cell carcinoma (LSCC) patients, 16 oral squamous cell carcinoma (OSCC) patients and 15 Oropharyngeal squamous cell carcinoma (OPSCC) patients diagnosed at the Brazilian National Cancer Institute (INCA, Rio de Janeiro, Brazil) were included in the study
In this study we showed that four subsites of UADT tumors analyzed in this study, ESCC, OSCC, OPSCC and LSCC, present marked differences among them regarding general profile, intensity, and genomic region of methylation changes, resulting in different genes and pathways affected, exemplified by the WNT pathway alteration analysis in the four subsites
Summary
Upper aerodigestive tract (UADT) tumors are highly incident worldwide and their prognosis vary according to tumor subsite and affected population [1,2]. A significant proportion of patients affected by these cancers develop a second primary tumor, synchronously or metachronously, either in the same subsite or at related anatomic subsites [4], usually resulting in a worse prognosis [5,6]. These cancers are not metastases, but tumor masses that develop independently of the first primary tumor and carry different driver molecular alterations [7]. Gaining insight into specific molecular alterations present in UADT tumor subsites is of critical importance
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.